Kemira Investor Presentation
Biobased strategy progressing
GROWTH ACCELERATOR FULLY OPERATIONAL
SINCE JANUARY 2023
•
.
.
Growth Accelerator unit aims to accelerate
commercialization of biobased and renewable
materials
PHA partnership: Technical work and customer trials
have continued with improving performance
Alfa Glucan partnership: Customer trials continued
with Paper & Board as well as Water Treatment
customers with positive customer feedback.
2023 targets: Programs in growth areas such as
textile fibers to expand significantly. Selected
investment decisions expected to enable future
growth.
BIOBASED REVENUE DEVELOPMENT
EUR million
Revenue growth since
2020 coming from
existing products, sizing
in particular. 2022
revenue growth price-
driven.
~250
~200
Kemira
APRIL 25, 2023
INVESTOR PRESENTATION
500
~100
2019
2020
2021
2022
2030 target
63View entire presentation